hemex – HEMEX

Clinical Development Press Release

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

Schlieren (Switzerland), 23rd March 2023 – hemotune AG, the Schlieren-based MedTech company known for [...]

Clinical Development Innovation Press Release

At the forefront of research into prevention of scar tissue formation after a heart attack

Resistell’s first patients recruited for international clinical study [...]

Clinical Development Innovation Press Release

Resistell’s first patients recruited for international clinical study in Switzerland, Spain and Austria

Resistell’s first patients recruited for international clinical study [...]

Innovation Investment Press Release

Reaching for the stars – ASPIVIX receives 510(k) clearance of Carevix™, Their Novel ATRAUMATIC Cervical Stabilizer from the U.S. FDA

HEMEX is proud to announce that our portfolio company ASPIVIX has received 510(k) clearance of [...]

Diversity Hemex Team Innovation

Empowering our people, transforming our world in 2023

New Year's resolutions can be a powerful way to make positive changes in life and [...]

HEMEX expands to China

Posted on November 15, 2019November 9, 2020 by Ivana Kresic

On 14th November 2019, our CEO Pascal Winnen signed a cooperation agreement with the Luoyang Science and Innovation Park in Henan, China’s most populated province. Under the Agreement, HEMEX will support the property developer Forton Group with attracting innovative Swiss startups for its newly built 133’000 m2 life science park. In exchange, HEMEX and its […]

Continue reading →